CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil-Reference-Cited by-同舟云学术

CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil

Published:2019-06-13 Issue:8 Volume:16 Page:3414-3429
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Keshavarz Ali¹,Alobaida Ahmed¹,McMurtry Ivan F.²,Nozik-Grayck Eva³,Stenmark Kurt R.³,Ahsan Fakhrul¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79430, United States

2. Department of Pharmacology, The Center for Lung Biology, University of South Alabama, Mobile, Alabama 36688, United States

3. Department of Pediatrics and Medicine, Cardiovascular Pulmonary Research Laboratories, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, United States

Funder

National Heart, Lung, and Blood Institute

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00208

Reference63 articles.

1. Exploiting the enhanced permeability and retention effect for tumor targeting

2. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

3. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems